A complete understanding of the regulation of PGC-1α expression in skeletal muscle has potential therapeutic value, since low levels of this coactivator are associated with a disruption of energy homeostasis [11], [46] and the manifestation of diseases such as insulin resistance and diabetes [12], [47]. Here, PPARGC1A is linked to Insulin resistance.